• Alpha-Thalassemia
  • TGFB3 Gene Mutation Analysis
  • Norovirus, EIA, Stool
  • Mumps Virus Antibody, IgG, IgM
  • Thoracic aortic aneurysm
  • Amphetamine, Urine
  • UDP-glucuronosyl Transferase 1A6 (UGT1A6) Genotyping
  • Lactate Dehydrogenase (LDH), Body Fluid
  • Electrophoresis, Protein, 24 Hour, Urine
  • Lymphocytic Choriomeningitis (LCM) Virus Antibodies, IgG & IgM, CSF
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

Methodology
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.